Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Budesonide in inflammatory bowel disease

C B Lamers1, M J Wagtmans, A van der Sluys Veer

  • 1Department of Gastroenterology-Hepatology, University Hospital Leiden, Netherlands.

The Netherlands Journal of Medicine
|February 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sofosbuvir plus simeprevir for the treatment of HCV genotype 4 patients with advanced fibrosis or compensated cirrhosis is highly efficacious in real life.

Journal of viral hepatitis·2016
Same author

Episodes of abdominal pain.

The Netherlands journal of medicine·2011
Same author

Relationship between pernicious anaemia and gastric neuroendocrine cell disorders.

The Netherlands journal of medicine·2000
Same author

Faecal parameters in the assessment of activity in inflammatory bowel disease.

Scandinavian journal of gastroenterology. Supplement·1999
Same author

Fecal lysozyme in assessment of disease activity in inflammatory bowel disease.

Digestive diseases and sciences·1998
Same author

Pancreatic secretory response to intrajejunal tryptophan: studies in dogs with an autotransplanted entire jejunoileum.

Pancreas·1997
Same journal

A diagnostic tool for self-poisoned patients: Analysis of gastric content and lavage fluids.

The Netherlands journal of medicine·2020
Same journal

Answer to Photoquiz A bone disorder with skin lesions.

The Netherlands journal of medicine·2020
Same journal

A bone disorder with skin lesions.

The Netherlands journal of medicine·2020
Same journal

Answer to Photoquiz A fascinating liver abscess.

The Netherlands journal of medicine·2020
Same journal

A fascinating liver abscess.

The Netherlands journal of medicine·2020
Same journal

Answer to Photoquiz A polyposis syndrome.

The Netherlands journal of medicine·2020
See all related articles

Budesonide, a topical glucocorticosteroid, shows efficacy in treating inflammatory bowel disease with fewer side effects than systemic options. It is effective for proctitis and Crohn's disease remission.

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Glucocorticosteroids are effective for inflammatory bowel disease (IBD) but systemic use is limited by side effects.
  • Topical glucocorticosteroids offer a safer alternative for IBD management.
  • Budesonide is a promising topical glucocorticosteroid with high potency and low systemic bioavailability.

Purpose of the Study:

  • To evaluate the efficacy and safety of budesonide in treating inflammatory bowel disease.
  • To compare budesonide's effectiveness with placebo, prednisolone, and 5-aminosalicylic acid.

Main Methods:

  • Administration of budesonide as an enema for proctitis/proctosigmoiditis.
  • Use of enteric-coated budesonide for ileocecal Crohn's disease.
  • Comparison of budesonide's efficacy against placebo and other treatments.

Related Experiment Videos

Main Results:

  • Budesonide enemas were more effective than placebo and comparable to prednisolone or 5-aminosalicylic acid enemas for proctitis.
  • Enteric-coated budesonide was more effective than placebo in achieving and maintaining remission in ileocecal Crohn's disease.
  • While rare, some hypothalamic-pituitary-adrenal axis suppression may occur with budesonide.

Conclusions:

  • Budesonide is an effective topical glucocorticosteroid for inflammatory bowel disease, offering a favorable risk-benefit profile.
  • Its localized action minimizes systemic side effects, making it a valuable treatment option for proctitis and Crohn's disease.